This was a multicenter , prospective , international , randomized ( 1:1 ) open-label superiority study of de novo enteric-coated mycophenolate sodium ( MPS ) vs delayed-onset everolimus ( RAD ) , both arms in combination with cyclosporine ( CsA ) monitored by 2-hour post-dose ( C2 ) levels , and corticosteroids .